Schematic model showing the mechanism by which both loss and overexpression of SLC7A11 mediate ferroptosis in the progression of MASLD Serine can be synthesized through transsulfuration pathway.

SAN DIEGO -- A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) up to 16 years before it occurs, according to a retrospective cohort study ...

WASHINGTON -- A large percentage of people with metabolic dysfunction-associated steatotic liver disease (MASLD) had their liver fat content normalize with an investigational dual agonist of the GLP-1 ...

In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — The risk for advanced fibrosis was similar among patients with lean and non-lean metabolic ...

If your diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) came as a surprise, you're not alone. Usually, you're diagnosed after a routine blood test shows higher than ...

MASLD significantly increases the risk of serious bacterial infections, with a two-fold increase in risk leading to hospitalization. Advanced MASLD stages, such as MASH, further elevate the risk of ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...

BOSTON — The nomenclature may have changed, but the steady rise in the most common form of liver disease — metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) — ...

MASLD is a significant risk factor for major cardiovascular events and all-cause mortality, with a rising global prevalence affecting 30% of adults. Cardiovascular disease is the leading cause of ...